Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers
Launched by LABORATOIRES URGO · Apr 21, 2017
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Assessment of efficacy, tolerance and acceptability of Urgo 310 3166 dressing in the treatment of local venous or mixed leg ulcers: multicenter trial, conducted in France.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female over 18 years old who has provided his/her written informed consent
- • 2. Patient who can be monitored by the same investigation team throughout the whole duration of the study
- • 3. Patient who agrees to wear an effective venous compression system every day, associated with the trial dressing
- • 4. Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more than 1.3
- • 5. Ulcer area between 3 and 20 cm2
- • 6. Ulcer duration between 3 and 18 months,
- • 7. Ulcer presenting a surface wound bed covered with 50% or more by granulation tissue
- • 8. Moderately or heavily exudative ulcers.
- Exclusion Criteria:
- • A. Clinical infection on the wound bed.
About Laboratoires Urgo
Laboratoires Urgo is a leading global healthcare company specializing in innovative wound care and advanced therapeutic solutions. With a commitment to enhancing patient outcomes, the company leverages cutting-edge research and development to create high-quality products that address a wide range of medical needs. Laboratoires Urgo's clinical trial initiatives focus on evaluating the efficacy and safety of its offerings, ensuring that they meet the highest standards of care. By fostering partnerships with healthcare professionals and institutions, Laboratoires Urgo aims to contribute to the advancement of medical science and improve the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chenôve, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials